Dr. Mark Lupo |
Fig. 01 -
Title Slide
Fig. 02 -
Disclosures
Fig. 03 -
Thyrotoxicosis Diagnosis
Fig. 04 -
Hypothyroidism
Fig. 05 -
When to Test
Fig. 06 -
Case 1
Fig. 07 -
Etiology
Fig. 08 -
I-123 Scan
Fig. 09 -
High and Low
Fig. 10 -
Recommendation 1
Fig. 11 -
Epidemiology–GD
Fig. 12 -
Often Unexplained
Fig. 13 -
Autoantibodies
Fig. 14 -
Antibodies
Fig. 15 -
TSI vs. RAIU
Fig. 16 -
Case 1 Psoriasis
Fig. 17 -
Treatment
Fig. 18 -
Favorable Prognostic Factors
Fig. 19 -
Mechanism
Fig. 20 -
Duration
Fig. 21 -
Duration Update
Fig. 22 -
Case 1 MMI
Fig. 23 -
Case 1 Stress
Fig. 24 -
Case 1 Summary
Fig. 25 -
Case 2
Fig. 26 -
TSH-R-Ab during pregnancy
Fig. 27 -
Utility of TSH-R-Ab
Fig. 28 -
Inhibition Graph
Fig. 29 -
Euthyroid Women
Fig. 30 -
Post-Partum
Fig. 31 -
Case 3
Fig. 32 -
Case 3 Diagnosis
Fig. 33 -
Case 3 Tremors
Fig. 34 -
Case 3 Summary
Fig. 35 -
Orbitopathy
Fig. 36 -
Case 4
Fig. 37 -
Case 4 Managed
Fig. 38 -
Several weeks later
Fig. 39 -
New Eye Swelling
Fig. 40 -
Case 4, TSH-R Ab Utility
Fig. 41 -
Summary- Cause
Fig. 42 -
Summary - HCG
TODO, let Pete know of any updates to this content
Six (6) provocative statements concerning clinical treatment of IBD. Each statement is presented as 5 steps:Step 1: the statement & introduction, + 5 possible opinions of that statement -- please choose one
Step 2: a graph of an international survey’s opinions of that statement
Step 3: a literature review for that statement
Step 4: a graph comparing the faculty's vs an international survey’s opinions, + faculty discussion
Step 5: a brief faculty summary, plus the list of references.
Please click on any Statement or any Step tab to read this publication in the order you prefer.